Jatho, A.; Zieseniss, A.; Brechtel-Curth, K.; Guo, J.; Böker, K.O.; Salinas, G.; Wenger, R.H.; Katschinski, D.M.
The HIFα-Stabilizing Drug Roxadustat Increases the Number of Renal Epo-Producing Sca-1+ Cells. Cells 2022, 11, 753.
https://doi.org/10.3390/cells11040753
AMA Style
Jatho A, Zieseniss A, Brechtel-Curth K, Guo J, Böker KO, Salinas G, Wenger RH, Katschinski DM.
The HIFα-Stabilizing Drug Roxadustat Increases the Number of Renal Epo-Producing Sca-1+ Cells. Cells. 2022; 11(4):753.
https://doi.org/10.3390/cells11040753
Chicago/Turabian Style
Jatho, Aline, Anke Zieseniss, Katja Brechtel-Curth, Jia Guo, Kai Oliver Böker, Gabriela Salinas, Roland H. Wenger, and Dörthe M. Katschinski.
2022. "The HIFα-Stabilizing Drug Roxadustat Increases the Number of Renal Epo-Producing Sca-1+ Cells" Cells 11, no. 4: 753.
https://doi.org/10.3390/cells11040753
APA Style
Jatho, A., Zieseniss, A., Brechtel-Curth, K., Guo, J., Böker, K. O., Salinas, G., Wenger, R. H., & Katschinski, D. M.
(2022). The HIFα-Stabilizing Drug Roxadustat Increases the Number of Renal Epo-Producing Sca-1+ Cells. Cells, 11(4), 753.
https://doi.org/10.3390/cells11040753